1. Home
  2. SGHT vs NCA Comparison

SGHT vs NCA Comparison

Compare SGHT & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • NCA
  • Stock Information
  • Founded
  • SGHT 2011
  • NCA 1987
  • Country
  • SGHT United States
  • NCA United States
  • Employees
  • SGHT N/A
  • NCA N/A
  • Industry
  • SGHT Medical Specialities
  • NCA Investment Managers
  • Sector
  • SGHT Health Care
  • NCA Finance
  • Exchange
  • SGHT Nasdaq
  • NCA Nasdaq
  • Market Cap
  • SGHT 304.4M
  • NCA 288.4M
  • IPO Year
  • SGHT 2021
  • NCA N/A
  • Fundamental
  • Price
  • SGHT $3.54
  • NCA $8.40
  • Analyst Decision
  • SGHT Buy
  • NCA
  • Analyst Count
  • SGHT 7
  • NCA 0
  • Target Price
  • SGHT $6.27
  • NCA N/A
  • AVG Volume (30 Days)
  • SGHT 234.0K
  • NCA 59.6K
  • Earning Date
  • SGHT 11-07-2024
  • NCA 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • NCA 3.92%
  • EPS Growth
  • SGHT N/A
  • NCA N/A
  • EPS
  • SGHT N/A
  • NCA N/A
  • Revenue
  • SGHT $79,543,000.00
  • NCA N/A
  • Revenue This Year
  • SGHT $2.18
  • NCA N/A
  • Revenue Next Year
  • SGHT $8.14
  • NCA N/A
  • P/E Ratio
  • SGHT N/A
  • NCA N/A
  • Revenue Growth
  • SGHT N/A
  • NCA N/A
  • 52 Week Low
  • SGHT $3.16
  • NCA $7.77
  • 52 Week High
  • SGHT $8.45
  • NCA $9.12
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 36.40
  • NCA 27.28
  • Support Level
  • SGHT $3.52
  • NCA $8.33
  • Resistance Level
  • SGHT $3.73
  • NCA $8.82
  • Average True Range (ATR)
  • SGHT 0.20
  • NCA 0.10
  • MACD
  • SGHT 0.01
  • NCA -0.03
  • Stochastic Oscillator
  • SGHT 24.54
  • NCA 14.81

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About NCA Nuveen California Municipal Value Fund

Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: